Trial Profile
A Randomized Clinical Trial of Glyburide (RP-1127) for TBI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Glibenclamide (Primary)
- Indications Traumatic brain injuries
- Focus Adverse reactions; Therapeutic Use
- Acronyms INTRuST-GLY
- Sponsors Remedy Pharmaceuticals
- 16 Jun 2021 Status changed from discontinued to completed.
- 05 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 31 Oct 2014 New trial record